- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
+0.70| Last Update: 05/17/13 - 4:00 PM EDT |
| Volume: 5,840,730 |
| YTD Performance: 15.86% |
| Open: $62.25 |
| Previous Close: $62.14 |
| 52 Week Range: $50.32 - $63.95 |
| Oustanding Shares: 1,020,007,037 |
| Market Cap: 63,383,237,279 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.26 | $1.54 | $5.44 | $5.84 |
| Number of Analysts | 12 | 12 | 14 | 14 |
| High Estimate | $1.34 | $1.60 | $5.65 | $6.40 |
| Low Estimate | $1.21 | $1.46 | $5.35 | $5.45 |
| Prior Year | $1.27 | $1.50 | $5.28 | $5.44 |
| Growth Rate (Year over Year) | -0.79% | 2.61% | 3.07% | 7.39% |
Today definitely did no real damage to the intermediate-term trend.
Its chart tells us that it's positioned to catch up to its peers.
The biggest, most-important, most-visible companies have done poorly.
UnitedHealth estimates reduced at UBSUNH earnings estimates through 2014 were reduced for sequestration and a more cautious MA outlook, said UBS.
Book profits, don't chase strength.
Upward momentum is lagging.
UnitedHealth target raised at Credit SuisseShares of UNH now seen reaching $71, according to Credit Suisse. PBM business is not being appreciated by investors. Outperform rating.
United Healthcare initiated a Buy at UBSUNH was initiated with a Buy rating, said UBS. The company's scale, cash flow and growth in the Optum business will drive upside to shares. Price target is $72.
Health Insurance names are leading a market rebound. Portfolio Manager David Peltier highlights Tuesday's early movers.
Worse-than-expected ISM report contributed to market weakness.